Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features

Bruna C Guido, Luciana M Ramos, Diego O Nolasco, Catharine C Nobrega, Bárbara YG Andrade, Aline Pic-Taylor, Brenno AD Neto, José R Corrêa
  • BMC Cancer, April 2015, Springer Science + Business Media
  • DOI: 10.1186/s12885-015-1274-1

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1186/s12885-015-1274-1

The following have contributed to this page: Dr Jose R. Correa and Brenno Neto